Auransa Company
Auransa is fundamentally changing the way drugs are discovered for conditions like cancer and Alzheimer’s disease.
Investors
Technology:
Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical, Therapeutics
Industry:
AI, Early Drug Development, Preclinical Development, United States
Headquarters:
Palo Alto, California, United States
Founded Date:
2014-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
18500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-08-24
Last Funding Type:
Series A
Register and Claim Ownership